Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease
Podlesniy, Petar, Figueiro‐Silva, Joana, Llado, Albert, Antonell, Anna, Sanchez‐Valle, Raquel, Alcolea, Daniel, Lleo, Alberto, Molinuevo, Jose Luis, Serra, Nuria, Trullas, Ramon·2013·Annals of Neurology
Cited by (219)
Items 201–219 of 219
- Reply to “Mitochondrial DNA deletions discriminate affected from unaffected LRRK2 mutation carriers”Rachit Bakshi, Eric A. Macklin, Michael A. Schwarzschild · 2019 · Annals of Neurology
- The relation between human biomarkers and oxidative stress in Alzheimer’s disease, novel in vivo experimental modelling possibilitiesZita Galik-Olah · 2018 · SZTE Repository of Dissertations (University of Szeged)
- a Circulating cell free mitochondrial DNA copy number variation in neurodegenerative diseaseHannah Lowes · 2018
- Ascorbate Deficiency Accelerates Neuropathology in Alzheimer's DiseaseShilpy Dixit · 2017
- Targeting Alzheimer's disease neuronal mitochondria as a therapeutic approachIsaac G. Onyango, Gorazd Bernard Stokin · 2020 · Elsevier eBooks
- Митохондриальные нарушения при болезни АльцгеймераVladimir S. Sukhorukov, Natalia M. Mudzhiri, Anastasiya S. Voronkova, Tatiana I. Baranich, Valeria V. Glinkina, Sergey Nikolaevich Illarioshkin · 2021 · Biochemistry (Moscow)
- Scarce metals in Swedish end-of-life vehicle recyclingMagnus Andersson, Maria Ljunggren Söderman, Björn A. Sandén · 2014 · Chalmers Publication Library (Chalmers University of Technology)
- Three Neurodegenerative Diseases: A Single HopeSarah H. Youssef, Hadeer N. Atalah, Marwa T. Badawy, Hassan A. N. El‐Fawal, Mohamed Salama · 2023 · Springer eBooks
- Additional file 1 of Associations between circulating cell-free mitochondrial DNA, inflammatory markers, and cognitive and physical outcomes in community dwelling older adultsLolita S. Nidadavolu, Danielle M. Feger, Diefei Chen, Wu, Yuqiong, Grodstein, Francine, Gross, Alden L., Bennett, David A., Walston, Jeremy D., Oh, Esther S., Peter M. Abadir · 2023 · Figshare
- Additional file 1 of Therapeutic non-invasive brain treatments in Alzheimer’s disease: recent advances and challengesWu, Chongyun, Luoman Yang, Feng, Shu, Zhu, Ling, Yang, Luodan, Timon Cheng‐Yi Liu, Rui Duan · 2022 · Figshare
- Toll-like receptor 9 contributes in microglial activation and lysosomal dysfunction to promote Alzheimer’s diseaseMoïse de Lavergne, Lucie Mazzola, Katrina Podsypanina, Cecilia Estrella, Philippe Verwaerde, Irini Evnouchidou, Guillaume Darrasse-Jèze, Marie‐Claude Potier, Sheela Vyas, Bénédicte Manoury · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
- Hallucinogenic Therapy in Alzheimer’s Disease targeting Mitochondria-Associated MembranesFernando Minauro‐Sanmiguel, Héctor Vargas-Pérez · 2026 · Neuroscience
- Glial molecular signatures as a liquid biopsy marker in Alzheimer’s disease diagnosisKunal Yadav, Sachin Suresh Tiwari · 2026 · International review of neurobiology
- Développement de tests diagnostiques par détection d'ADN extracellulaireRita Tanos · 2019
- Plasma Proteomic Networks Reveal Shared Biology with Brain Linked to Alzheimer’s Disease PathologyQI GUO, Lingyan Ping, Saima Rathore, Duc M. Duong, Anantharaman Shantaraman, Edward J. Fox, Erik C. B. Johnson, James J. Lah, Allan I. Levey, Nicholas T. Seyfried · 2026 · medRxiv
- Reshaping the immune landscape: next-generation microglia-targeted therapies for Alzheimer’s diseaseJianmin Wu, J J Zhao, S Y Chen, Fangyi Xu · 2026 · Biological Research
- Blood biomarkers of oxidative stress and mitochondrial dysfunction in Parkinson’s disease and Alzheimer’s diseaseDeepak Kumar, Snehasish Shee, Ashok Kumar Datusalia, Shyam Sunder Sharma · 2026 · International review of neurobiology
- Mitochondrial oxidative stress as a convergent redox mechanism in neurodegeneration: Molecular pathways, biomarkers, and emerging therapeutic opportunitiesMd. Shoriful Islam, Md Tawhed Islam, Munna Mondol, Ibtasum Islam, Kazi Muhtasim Fuad, Md. Faysal Abid, Sheikh Tajim, Rafia Ferdous · 2026 · Advances in Redox Research
- Mitochondrial dysfunction in neurology: biomarkers and clinical implicationsElena Rossini, Matteo Garibaldi, Michael G. Hanna, Robert D. S. Pitceathly, Chiara Pizzamiglio · 2026 · Nature Reviews Neurology